Related Experiment Videos
[Pleurisy in HIV infected patients]
I Allier1, J Cadranel, F Parquin
1Service de Pneumologie et de Réanimation respiratoire, Hôpital Tenon, Paris.
Presse Medicale (Paris, France : 1983)
|November 23, 1991
Summary
Kaposi sarcoma effusions in HIV-positive patients often present bilaterally and are hemorrhagic. These distinct features, unlike infectious effusions, aid in diagnosing pleural effusion causes in HIV patients.
Area of Science:
- Medical research
- Pulmonology
- Infectious diseases
Background:
- HIV-seropositive patients are susceptible to various pleural effusions.
- Differentiating between Kaposi sarcoma and infectious effusions is crucial for patient management.
Purpose of the Study:
- To retrospectively analyze pleural effusion characteristics in HIV-seropositive patients.
- To identify distinguishing features between Kaposi sarcoma and infectious pleural effusions.
Main Methods:
- Retrospective analysis of 37 HIV-seropositive patients with known pleural effusion causes.
- Division of patients into two groups: Kaposi sarcoma effusions (n=21) and infectious effusions (n=16).
- Comparison of clinical, radiological, and effusion characteristics between the two groups.
Main Results:
- Kaposi sarcoma effusions were significantly associated with cutaneous Kaposi sarcoma (20/21), slow onset (>10 days) (20/21), bilateral presentation (20/21), and hemorrhagic nature (18/21).
- Infectious effusions served as a control group for comparison.
- Fever was less common in Kaposi sarcoma effusions (4/21).
- Bilateral parenchymal opacities were frequently observed with Kaposi sarcoma effusions.
Conclusions:
- Simple clinical and radiological features can effectively predict the cause of pleural effusion in HIV-seropositive individuals.
- These features can guide the diagnostic approach, differentiating Kaposi sarcoma from infectious causes.
- Early identification of effusion type is vital for appropriate therapeutic strategies.